US Migraine Market and Competitive Landscape Highlights - 2016

  • ID: 3679128
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Migraine Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine products sales and competitive landscape in the US.

The research is classified into nine sections – Migraine overview including etiology, pathophysiology, and diagnosis, Migraine treatment options, Migraine pipeline products, Migraine market analysis comprising of Migraine epidemiology, key products marketed for Migraine, market valuations and forecast, products sales and market shares.

Research Scope:
- Migraine Pipeline: Find out the products in clinical trials for the treatment of Migraine by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Migraine Epidemiology: Find out the number of patients diagnosed (prevalence) with Migraine in the US
- Migraine Products: Identify key products marketed and prescribed for Migraine in the US, including trade name, molecule name, and company
- Migraine Product Sales: Find out the sales revenues of Migraine products, both branded and generics, in the US
- Migraine Market Valuations: Find out the market size for Migraine products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Migraine Products Market Share: Find out the market shares for key Migraine products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Migraine market analysis and sales trends
- Track competitor drugs sales and market share in the US Migraine market
- Track competitive developments in Migraine market and present key issues and learnings
- Synthesize insights for Migraine market and products to drive business performance
- Answer key business questions about the Migraine market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Migraine products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Migraine Treatments
3) Migraine Pipeline
4) US Migraine Epidemiology
5) Marketed Drugs for Migraine in US
6) US Migraine Market Size
7) US Migraine Products Sales
8) US Migraine Market Competitive Landscape
9) US Migraine Market Forecast
10) Methodology
11) Contact us

1. Migraine Epidemiology, US, 2010 - 2020
2. Migraine Market Size ($), US, 2010 – 2015
3. Migraine Products Market Share (%), US, 2015
4. Migraine Market Forecast ($), US, 2015 – 2020

1. Migraine Phase 3 Clinical Trials, 2016
2. Migraine Phase 2 Clinical Trials, 2016
3. Migraine Phase 1 Clinical Trials, 2016
4. Migraine Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Migraine, US, 2016
6. Migraine Market Size ($), US, 2010 – 2015
7. Migraine Product Sales ($), US, 2010 – 2015
8. Migraine Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll